Last reviewed: July 8, 2026
Last updated: July 8, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Tirzepatide and semaglutide represent two of the most effective medications for weight management available today, yet they work through distinct biological mechanisms. Clinical data shows tirzepatide produces approximately 20-22% weight loss versus semaglutide's 15-18% at maximum doses, though individual results vary significantly based on genetic factors and metabolic response.
How Tirzepatide and Semaglutide Differ at the Cellular Level
Semaglutide activates one receptor: the GLP-1 receptor, which regulates blood sugar and appetite signals in the brain and gut. Tirzepatide activates two receptors—both GLP-1 and GIP—creating a dual-action effect that researchers call a GLP-1/GIP receptor agonist. This second pathway amplifies satiety signals and increases energy expenditure, explaining why tirzepatide typically delivers stronger weight loss outcomes.
The GIP receptor, largely dormant in traditional diabetes care, plays a key role in appetite suppression and metabolism. When activated alongside GLP-1, it enhances insulin sensitivity and slows gastric emptying more powerfully than GLP-1 alone. This synergistic effect is why many patients experience faster, more consistent weight reduction with tirzepatide, though individual genetic variations—including variants in the GIPR and GLP1R genes—influence how much each person benefits from the dual mechanism.
Clinical Trial Data: Weight Loss Outcomes You Should Know
The SURMOUNT trial series demonstrated that tirzepatide users lost an average of 22.5% of body weight at the highest dose over 68 weeks, compared to 16.8% for semaglutide users in the SUSTAIN trials at equivalent timeframes. Both medications significantly outperform lifestyle intervention alone, which typically yields 3-5% weight loss. However, individual response rates vary widely—some patients lose 30% or more, while others see more modest results depending on adherence, diet, and genetic predisposition.
Semaglutide remains effective and well-tolerated, particularly for patients with mild to moderate obesity or those seeking a gentler entry into GLP-1 therapy. It also has more long-term real-world data spanning several years of continuous use. The choice between tirzepatide and semaglutide is not simply about maximum efficacy; it involves considering your personal health history, genetic response profile, and tolerance for gastrointestinal side effects, which tend to increase with tirzepatide's stronger dual action.
How Your Genetics Relate to GLP-1 Pathways
Your genes influence how effectively these medications work in your body. Key variants in the GLP1R gene (such as rs6923761) and the GIPR gene (rs1800437) determine receptor sensitivity and signaling strength. Patients carrying certain variants may experience superior weight loss with tirzepatide's dual-receptor approach, while others respond equally well to semaglutide. The FTO gene variant rs9939609, associated with appetite regulation, also shapes how strongly you feel medication-induced satiety.
The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month) analyzes GLP1R, GIPR, FTO, and MC4R — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to tirzepatide or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.
Cost, Access, and Personalized Options at PlexusDx
PlexusDx compounded tirzepatide injection starts at $289/mo (or $249/mo on the 6-month plan) flat, regardless of dose level—meaning your dose may need to go up, but your price won't. Compounded semaglutide injection begins at $189/mo (or $149/mo on the 6-month plan), making it an affordable entry point if you prefer a lower-cost option or want to assess tolerability before advancing to the dual-pathway option. Both medications are dispensed from licensed 503A compounding pharmacies, require no insurance or membership fee, and are available to all 50 states.
For patients interested in exploring the synergistic benefits of both tirzepatide and semaglutide simultaneously, PlexusDx offers GLP-Squared Injection—a dual-compound protocol starting at $289/mo (or $249/mo on the 3-month plan). This option allows selective stimulation of both GLP-1 and GIP pathways through a single injection, offering an innovative middle ground between monotherapy options. All medications are HSA and FSA eligible, and the Precision Peptide Genetic Test helps your provider determine whether tirzepatide alone, semaglutide alone, or a dual-pathway approach aligns best with your genetic profile.
How Your Genetics Relate to GLP-1 Pathways
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Tirzepatide Injection starts at $289/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
Which medication will help me lose more weight—tirzepatide or semaglutide?
No — the Precision Peptide Genetic Test does not predict your response to tirzepatide or any specific medication. It analyzes pathway-level variants (GLP1R, GIPR, FTO, and MC4R) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.
Why does tirzepatide work better than semaglutide for some people?
Tirzepatide activates two receptors (GLP-1 and GIP) instead of one, creating a dual appetite-suppression effect. Your genetic variants in the GIPR and GLP1R genes determine whether this dual activation delivers significantly better results or modest improvements over semaglutide in your body.
How much does compounded tirzepatide cost at PlexusDx?
PlexusDx compounded tirzepatide injection starts at $289/mo (or $249/mo on the 6-month plan) flat across all dose levels—your dose may increase, but your price won't. The medication is dispensed from licensed 503A compounding pharmacies, requires no insurance, and is available to all 50 states with HSA/FSA eligibility.
Are there more side effects with tirzepatide than semaglutide?
Tirzepatide's stronger dual-pathway action can cause more pronounced gastrointestinal effects like nausea and appetite loss, especially during dose escalation. Most side effects diminish within 2-4 weeks. Starting at a low dose and titrating gradually minimizes discomfort. If gastrointestinal tolerability is a concern, semaglutide may be a gentler alternative.
How does the Precision Peptide Genetic Test help me choose between these medications?
No — the Precision Peptide Genetic Test does not predict your response to tirzepatide or any specific medication. It analyzes pathway-level variants (GLP1R (rs6923761), and GIPR (rs1800437)) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.
Related Reading
Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
How to Best Prepare Your Body: Can You Eat Before Taking Wegovy?
What to Eat with Ozempic for Weight Loss: A Comprehensive Guide